siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival

β-Catenin, the chief oncogenic component of the canonical Wnt pathway, is known to be involved in a variety of cancers, including hepatocellular carcinoma (HCC). Although the mechanism of β-catenin activation in HCC is multifactorial, it is indisputably implicated at various stages of hepatocarcinog...

Full description

Bibliographic Details
Main Authors: Gang Zeng, Udayan Apte, Benjamin Cieply, Sucha Singh, Satdarshan P.S. Monga
Format: Article
Language:English
Published: Elsevier 2007-11-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558607800236
_version_ 1811265700111581184
author Gang Zeng
Udayan Apte
Benjamin Cieply
Sucha Singh
Satdarshan P.S. Monga
author_facet Gang Zeng
Udayan Apte
Benjamin Cieply
Sucha Singh
Satdarshan P.S. Monga
author_sort Gang Zeng
collection DOAJ
description β-Catenin, the chief oncogenic component of the canonical Wnt pathway, is known to be involved in a variety of cancers, including hepatocellular carcinoma (HCC). Although the mechanism of β-catenin activation in HCC is multifactorial, it is indisputably implicated at various stages of hepatocarcinogenesis, making it an attractive therapeutic target. Here we investigate the effect of small interfering RNA-mediated β-catenin knockdown on the growth and survival of human hepatoma cell lines with (HepG2) and without (Hep3B) β-catenin mutations. Transfection of HepG2 and Hep3B cells with human β-catenin (CTNNBl) small interfering RNA resulted in a significant β-catenin decrease, as confirmed by Western blot analyses and immunofluorescence, also leading to decreased expression of known target genes such as cyclin D1 and glutamine synthetase. The decrease in β-catenin activity was confirmed by TOPflash reporter luciferase assay. The functional impact of diminished β-catenin was exhibited as temporal decrease in tumor cell viability by the MTT assay. A concomitant decrease in tumor cell proliferation was also evident with [3H]thymidine incorporation and verified with soft agar assays. Thus, β-catenin is essential for the survival and growth of hepatoma cells independent of mutations in the β-catenin gene and provide a proof of principle for the significance of the therapeutic inhibition of β-catenin in HCC.
first_indexed 2024-04-12T20:27:36Z
format Article
id doaj.art-c1a4ed6d325f45f69bcbfd931529cb75
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-04-12T20:27:36Z
publishDate 2007-11-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-c1a4ed6d325f45f69bcbfd931529cb752022-12-22T03:17:49ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022007-11-0191195195910.1593/neo.07469siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and SurvivalGang Zeng0Udayan Apte1Benjamin Cieply2Sucha Singh3Satdarshan P.S. Monga4Departments of Pathology, University of Pittsburgh, SOM, Pittsburgh, PA 15213. USADepartments of Pathology, University of Pittsburgh, SOM, Pittsburgh, PA 15213. USADepartments of Pathology, University of Pittsburgh, SOM, Pittsburgh, PA 15213. USADepartments of Pathology, University of Pittsburgh, SOM, Pittsburgh, PA 15213. USADepartments of Pathology, University of Pittsburgh, SOM, Pittsburgh, PA 15213. USAβ-Catenin, the chief oncogenic component of the canonical Wnt pathway, is known to be involved in a variety of cancers, including hepatocellular carcinoma (HCC). Although the mechanism of β-catenin activation in HCC is multifactorial, it is indisputably implicated at various stages of hepatocarcinogenesis, making it an attractive therapeutic target. Here we investigate the effect of small interfering RNA-mediated β-catenin knockdown on the growth and survival of human hepatoma cell lines with (HepG2) and without (Hep3B) β-catenin mutations. Transfection of HepG2 and Hep3B cells with human β-catenin (CTNNBl) small interfering RNA resulted in a significant β-catenin decrease, as confirmed by Western blot analyses and immunofluorescence, also leading to decreased expression of known target genes such as cyclin D1 and glutamine synthetase. The decrease in β-catenin activity was confirmed by TOPflash reporter luciferase assay. The functional impact of diminished β-catenin was exhibited as temporal decrease in tumor cell viability by the MTT assay. A concomitant decrease in tumor cell proliferation was also evident with [3H]thymidine incorporation and verified with soft agar assays. Thus, β-catenin is essential for the survival and growth of hepatoma cells independent of mutations in the β-catenin gene and provide a proof of principle for the significance of the therapeutic inhibition of β-catenin in HCC.http://www.sciencedirect.com/science/article/pii/S1476558607800236Liver cancerWnt/β-catenindevelopmenttreatmentregeneration
spellingShingle Gang Zeng
Udayan Apte
Benjamin Cieply
Sucha Singh
Satdarshan P.S. Monga
siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
Neoplasia: An International Journal for Oncology Research
Liver cancer
Wnt/β-catenin
development
treatment
regeneration
title siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
title_full siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
title_fullStr siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
title_full_unstemmed siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
title_short siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
title_sort sirna mediated β catenin knockdown in human hepatoma cells results in decreased growth and survival
topic Liver cancer
Wnt/β-catenin
development
treatment
regeneration
url http://www.sciencedirect.com/science/article/pii/S1476558607800236
work_keys_str_mv AT gangzeng sirnamediatedbcateninknockdowninhumanhepatomacellsresultsindecreasedgrowthandsurvival
AT udayanapte sirnamediatedbcateninknockdowninhumanhepatomacellsresultsindecreasedgrowthandsurvival
AT benjamincieply sirnamediatedbcateninknockdowninhumanhepatomacellsresultsindecreasedgrowthandsurvival
AT suchasingh sirnamediatedbcateninknockdowninhumanhepatomacellsresultsindecreasedgrowthandsurvival
AT satdarshanpsmonga sirnamediatedbcateninknockdowninhumanhepatomacellsresultsindecreasedgrowthandsurvival